IRMD
IRADIMED CORPORATION96.87
-0.15-0.16%
Dec 16, 4:00:01 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
No earnings call transcript available
Key Stats
Market Cap
1.23BP/E (TTM)
58.71Basic EPS (TTM)
1.65Dividend Yield
0.01%Recent Filings
8-K
8-K
10-Q
8-K
Board transition at Iradimed
Iradimed Corporation announced a board transition on August 27, 2025, when director Anthony Vuoto retired for personal reasons, effective immediately, after nine years of service. The board swiftly appointed Joe Kiani, Masimo founder and medical tech innovator, as his replacement on September 2, 2025, maintaining the five-member size while adding his audit and compensation committee expertise. Kiani's deep industry knowledge bolsters strategic guidance. No disagreements prompted Vuoto's exit.
8-K
Record Q2 revenue, raised guidance
Iradimed posted record Q2 2025 revenue of $20.4 million, up 14% from last year, with GAAP diluted EPS climbing 18% to $0.45 amid a steady 78% gross margin. The company raised full-year guidance to $80.0-$82.5 million in revenue and $1.60-$1.70 GAAP EPS, signaling robust demand for its MRI-compatible devices. It declared a $0.17 quarterly dividend, payable August 28. Yet facility move risks Q3 inefficiencies.
BIO
Bio-Rad Laboratories, Inc.
302.02-5.90
CNMD
CONMED Corporation
39.20-1.12
INMD
InMode Ltd.
14.48+0.15
IRIX
IRIDEX Corporation
1.00+0.02
IRME
IR-Med Inc.
0.02-0.01
ITGR
Integer Holdings Corporation
73.90+0.81
MASI
Masimo Corporation
134.52-2.88
MDT
Medtronic plc.
97.72-0.85
RMD
ResMed Inc.
247.34-5.73
VMD
Viemed Healthcare, Inc.
7.26-0.11